跳至主要内容
临床试验/JPRN-UMIN000006224
JPRN-UMIN000006224
已完成
未知

Evaluation of efficiency and safety of a new hip arthroplasty implant(AMU001)for patients with hip joint diseases - Clinical study of a new prosthesis for total hip arthroplasty (AMU001)

Asahikawa Medical University Hospital Orthopaedics0 个研究点目标入组 30 人2011年9月1日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Osteoarthritis of the Hip, Osteo necrosis of the Femoral Head, Rheumatoid arthritis
发起方
Asahikawa Medical University Hospital Orthopaedics
入组人数
30
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2011年9月1日
结束日期
2014年3月1日
最后更新
2年前
研究类型
Interventional
性别
All

研究者

发起方
Asahikawa Medical University Hospital Orthopaedics

入排标准

入选标准

  • 未提供

排除标准

  • (1\) Patient had previously received hip prosthesis in the same hip joint. (2\) Patient received artificial joint prosthesis in lower extremity within 180 days. (3\) In the other side of the hip; 1\) loosening of total hip arthroplasty or hemiarthroplasty 2\) osteotomy or soft tissue release around hip joint is scheduled within one year (4\) Charnley category C (5\) Body weight\>\=80kg, BMI\>\=30 (6\) Severe osteoporosis (7\) Abscess or infection around hip joint (8\) Metal allergy (9\) It is difficult to follow the hip precautions due to neurological disorder, mental illness, alcohol dependence, or drug abuse. (10\) joined other clinical trial within 90 days (11\) in pregnancy or scheduled to become pregnant during this clinical trial. (12\) it is not possible to stop to use anticoagulant or antiplatelet drug from one week before surgery. (13\) Patient who is determined to be excluded from the clinical trial due to any reasons by the study doctor.

结局指标

主要结局

未指定

相似试验